Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Standard Biotools (LAB) Divestments (2020 - 2026)

Standard Biotools has reported Divestments over the past 2 years, most recently at $2.0 million for Q3 2021.

Quarterly Divestments fell 82.06% to $2.0 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Sep 2022, down 87.41% year-over-year, with the annual reading at $1.3 million for FY2021, 93.73% down from the prior year.
Divestments was $2.0 million for Q3 2021 at Standard Biotools, roughly flat from $2.0 million in the prior quarter.
Over five years, Divestments peaked at $11.2 million in Q3 2020 and troughed at $2.0 million in Q1 2021.